India, July 30 -- A rare type of cancer that begins in the bones, bone cancer, or bone neoplasm, is known to be fatal, with a five-year relative survival rate of 68.2 percent. According to the American Cancer Society's estimates for primary cancer of the bones and joints in 2025, about 3,770 new cases will be diagnosed (2,150 in males and 1,620 in females) and about 2,190 deaths (1,240 in males and 950 in females). This includes cancers in both children and adults.

This makes understanding the genetic factors that contribute to its development crucial for early detection and treatment. According to Dr Haresh Manglani, orthopaedic onco-surgeon, HCG ICS Khubchandani Cancer Centre, Mumbai (Colaba), research has shown that certain genetic mu...